Public Resources For Pandemic Response Manufacturing Capacity
Source: Bioprocess Online
In this segment of the BioProcess Online Live event The Next Pandemic: Biopharma's Opportunities and Obligations, Heat Biologics Founder & CEO Jeff Wolf, Massachusetts Biomedical Initiatives President & CEO Jon Weaver, and Lakes BioScience Chief Strategy and Technology Officer Adrian Wallis discuss public resource availability for biopharma companies seeking manufacturing capacity to ramp up production of vaccines and therapeutics in the face of public health emergencies.
View the full presentation on-demand here.
This website uses cookies to ensure you get the best experience on our website. Learn more